Removes exception of self-insured health benefits plans from law concerning pharmacy benefits managers.
If enacted, A1763 would significantly impact the landscape of health benefits management in New Jersey by ensuring that self-insured health plans adhere to the same legal and operational standards as fully insured plans. By eliminating their exemption from state laws governing PBM practices, the bill aims to increase protection for consumers, ensuring better transparency and fairness in pharmaceutical pricing and access to medications. Additionally, it calls for a report from the Department of Banking and Insurance on the implications of the recent US Supreme Court ruling, Rutledge v. Pharmaceutical Care Management Association, which could further refine the legal context surrounding pharmacy benefit management in the state.
Assembly Bill A1763, sponsored by Assemblyman John F. McKeon, seeks to amend existing regulations regarding pharmacy benefits managers (PBMs) by removing the exemption for self-insured health benefits plans that are governed by the federal Employee Retirement Income Security Act of 1974 (ERISA). This legislative change is expected to bring self-insured plans under state jurisdiction concerning the management of pharmacy benefits, thereby enforcing more stringent oversight and compliance requirements that apply to other health benefits plans. The bill addresses issues related to the procurement of prescription drugs and the processing of related claims, aiming to create a more uniform regulatory environment for PBMs in New Jersey.
There are notable points of contention regarding A1763, particularly surrounding the balance of state versus federal regulatory authority over health benefit plans. Supporters of the bill argue that it is necessary for consumer protection and to rectify inequities in how self-insured plans have operated outside of state oversight. Critics, however, may raise concerns about the federal pre-emption of state laws and the implications that state mandates may have on the cost and availability of self-insured plans. The effectiveness of this bill in addressing the broader issues of health care costs and access will likely be pivotal in ongoing legislative discussions.